Is IVUS Useful in Lower Limb PCI?

Peripheral vascular disease is on the rise and peripheral PCI is at present the first choice of treatment for most patients. 

¿Es útil el IVUS en las angioplastias de los miembros inferiores?

The use of IVUS in femoropopliteal territory has shown great benefits, especially in left main and complex PCI, reducing mortality and restenosis but, though promising, in lower limb ischemia we have little information as regards outcomes. 

The study looked at 85649 patients undergoing PCI in Japan. 50925 (59.5%) were done using IVUS. 

Primary end point was major or minor amputation at 12 months after procedure. 

Mean age was 74 and over 70% were men. Patients receiving IVUS presented more comorbidities, dementia, interactions and received more devices (stents, DEB, and atherotome); therefore, patients were match with propensity score, which left 31534 patients in each group. 

Read also: Post PCI Angina: Inevitable or Avoidable?

Primary end point resulted in favor of the IVUS group (6.9% vs. 9.3%HR, 0.80 [95% CI, 0.72–0.89] p<0.001). Also, this populations presented lower need for CABG (2.5% vs. 4.9% HR, 0.51[95% CI, 0.44–0.60] p<0.001) and stent graft vs. Non-IVUS patients, while they did present more reintervention and readmission with no difference in mortality.

Total hospitalization cost was lower with IVUS.

Conclusion

In this retrospective study, IVUS guided peripheral PCI was associated to lower amputation risk vs. peripheral PCI not guided by IVUS. These data should be interpreted with caution given its limitations as an observational study. Further research is required for researchers to be able to confirm the use of IVUS will lead to lower amputation rates. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Amputation After Endovascular Therapy With and Without Intravascular Ultrasound Guidance: A Nationwide Propensity Score–Matched Study.

Reference: Nao Setogawa, et al. Circ Cardiovasc Interv. 2023;16:e012451. DOI: 10.1161/CIRCINTERVENTIONS.122.012451.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...